Nudging people with Type 2 diabetes towards sustained adherence to self-management: a cluster randomized controlled trial

推动 2 型糖尿病患者持续坚持自我管理：一项整群随机对照试验

基本信息

批准号：
20K18934
负责人：
Rouyard Thomas
金额：
$ 2.58万
依托单位：
Hitotsubashi University
依托单位国家：
日本
项目类别：
Grant-in-Aid for Early-Career Scientists
财政年份：
2020
资助国家：
日本
起止时间：
2020-04-01 至 2024-03-31
项目状态：
已结题

项目摘要

- The study aims to evaluate the effects of a personalized behavioral intervention (‘FEEDBACK’) developed to improve self-management behavior in adults with type 2 diabetes. FEEDBACK is a resource-minimizing intervention designed to be delivered by general practitioners (GPs) in routine primary care settings. The study is a cluster randomized controlled trial (RCT) with six months follow-up.- In Japan, where the implementation of primary care policy has just begun, it is necessary to introduce evidence-based, person-centered diabetic care into the practice of GPs nationwide. If we could link our FEEDBACK intervention with improved patient outcomes and delivery in primary care, this would provide further justification for stronger primary care services and investment in primary care in Japan.2022:- After numerous study implementation challenges and delays encountered in 2020 and 2021 due to the COVID-19 pandemic, we have now managed to make good progress in the recruitment process. Eighteen GP practices have been recruited so far, which is close to our initial sample size objective (n=20). We would like to recruit a few more practices to ensure that our pre-registered minimum effect size of interest can be detectable.- As we made good process on the recruitment process, we submitted the study protocol for publication in an international peer-reviewed journal in January 2023. The manuscript has been accepted for publication in the journal 'Trials'.

- 该研究旨在评估为改善2型糖尿病成年人的自我管理行为而开发的个性化行为干预（“反馈”）的影响。反馈是一种资源最少的干预措施，旨在由普通实践者（GPS）在常规初级保健环境中提供。该研究是一项群集随机对照试验（RCT），随访了六个月。-在日本，在初级保健政策的实施刚刚开始的情况下，有必要将基于证据的，以人为本的糖尿病护理引入全国GPS实践。如果我们可以将反馈干预与改善的患者结局联系起来并在初级保健中提供的分娩，那么这将为日本更强大的初级保健服务和对初级保健的投资提供进一步的理由。2022： - 在2020年和2021年遇到的许多研究实施挑战和延误之后，由于COVID-19 Pandemic，我们现在已经在招聘过程中取得了良好的进步。到目前为止，已经招募了18种GP实践，这接近我们最初的样本量目标（n = 20）。我们想招募更多的实践，以确保可以检测到我们的预先注册的最小效果大小。